Industry Reports

Hana Securities: Alteogen's ALT-B4 is no imitation

Hana Securities: Alteogen's ALT-B4 is no imitation

A South Korean brokerage has moved to dispel market confusion over a rival hyaluronidase platform, arguing that Alteogen's proprietary enzyme retains a clear edge over any biosimilar competitor.

15 July 2026

Kyobo Securities raises KT&G target price to 250,000 won

Kyobo Securities raises KT&G target price to 250,000 won

A sharp rise in foreign ownership and accelerating next-generation tobacco sales have prompted Kyobo Securities to lift its target price for KT&G by 32%, benchmarking the South Korean tobacco giant against Philip Morris International.

7 July 2026

Korean Bank Stocks Rise 5% as KOSPI Slumps

As South Korea's benchmark index suffered its sharpest fall in years, bank stocks bucked the trend — and analysts say the sector's attractions go beyond mere safe-haven appeal.

3 July 2026

TMC: A Cable Maker's Profitable Pivot

A South Korean industrial cable manufacturer is quietly shifting from low-margin marine cables towards high-margin speciality products, with the full earnings impact expected to materialise by 2027.

22 June 2026

iM Securities raises LS target price to 570,000 won

Surging power-cable order books, copper price tailwinds, and regulatory reforms that should shrink a persistent holding-company discount make LS one of South Korea's more compelling industrial plays.

22 June 2026

DS Securities raises KT&G target price to 240,000 won

A sharply narrowed valuation discount to global peer Philip Morris International, surging overseas cigarette sales, and an aggressive shareholder-return programme are driving a re-rating of South Korea's dominant tobacco group.

19 June 2026